The outcomes of lower extremity revascularization: What role do race, ethnicity, and socioeconomic status play?

医学 血运重建 社会经济地位 民族 跛行 严重肢体缺血 背景(考古学) 物理疗法 疾病 内科学 血管疾病 动脉疾病 人口 心肌梗塞 环境卫生 古生物学 社会学 生物 人类学
作者
William P. Robinson
出处
期刊:Seminars in Vascular Surgery [Elsevier BV]
卷期号:36 (1): 69-77 被引量:1
标识
DOI:10.1053/j.semvascsurg.2023.01.008
摘要

Lower extremity peripheral artery disease and the resultant complications disproportionately affect underrepresented racial and ethnic minority groups, as well as those with low socioeconomic status (SES). Revascularization, including both open surgical and endovascular techniques, is a mainstay of therapy for symptomatic peripheral artery disease; it is required to maximize limb salvage in chronic limb-threatening ischemia and used to improve function and quality of life in patients with claudication. The outcomes of lower extremity revascularization in Black and Hispanic patients, as well as patients with low SES, are not widely known and this knowledge gap formed the basis for this review. The preponderance of evidence suggests that Black, Hispanic, and low-SES patients have inferior limb-related outcomes after revascularization compared with White patients. Based solely on the limited published evidence in the revascularization literature, the specific reasons for these disparities are not clear. The high prevalence of comorbidities and risks factors, as well as the advanced presentation of peripheral artery disease in Black, Hispanic, and low-SES patients, appear to contribute to the inferior limb outcomes post revascularization seen in these groups, but do not account for all of the disparities. Undoubtedly, a complex interplay of social determinants underlies these disparities in care and outcomes at individual, community, and societal levels. Additional understanding of the underpinnings and mechanisms of inferior outcomes in these populations in the specific context of lower extremity revascularization is needed, as this would allow us to identify targets for intervention to improve post-revascularization outcomes in these at-risk populations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
侃侃完成签到,获得积分10
1秒前
俞拽拽发布了新的文献求助10
1秒前
Erin完成签到 ,获得积分10
2秒前
合适秋凌应助zxd1999采纳,获得10
2秒前
2秒前
科研通AI5应助ycf采纳,获得10
2秒前
3秒前
丰富的乐儿完成签到,获得积分10
3秒前
852应助Rjy采纳,获得10
3秒前
LTDJYYD完成签到,获得积分10
3秒前
酷酷傲珊应助啊实打实的采纳,获得10
3秒前
4秒前
4秒前
5秒前
6秒前
orixero应助LLP采纳,获得10
6秒前
ZHAO发布了新的文献求助10
6秒前
思源应助strug783采纳,获得10
7秒前
7秒前
跳跃的翼应助科研通管家采纳,获得10
7秒前
隐形曼青应助科研通管家采纳,获得10
8秒前
丘比特应助科研通管家采纳,获得10
8秒前
8秒前
香蕉觅云应助科研通管家采纳,获得10
8秒前
8秒前
隐形曼青应助科研通管家采纳,获得10
8秒前
斯文败类应助科研通管家采纳,获得10
8秒前
桐桐应助科研通管家采纳,获得10
8秒前
大胆的向卉完成签到,获得积分10
8秒前
8秒前
千空应助科研通管家采纳,获得10
9秒前
脑洞疼应助科研通管家采纳,获得10
9秒前
思源应助科研通管家采纳,获得10
9秒前
烟花应助科研通管家采纳,获得10
9秒前
NexusExplorer应助科研通管家采纳,获得30
9秒前
9秒前
Meyako应助科研通管家采纳,获得10
9秒前
NexusExplorer应助科研通管家采纳,获得10
9秒前
小马甲应助科研通管家采纳,获得80
9秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
줄기세포 생물학 1000
Biodegradable Embolic Microspheres Market Insights 888
Quantum reference frames : from quantum information to spacetime 888
Pediatric Injectable Drugs 500
Instant Bonding Epoxy Technology 500
ASHP Injectable Drug Information 2025 Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4402637
求助须知:如何正确求助?哪些是违规求助? 3889543
关于积分的说明 12105514
捐赠科研通 3534105
什么是DOI,文献DOI怎么找? 1939209
邀请新用户注册赠送积分活动 980015
科研通“疑难数据库(出版商)”最低求助积分说明 877029